Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 22, 2026
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
09:00am, Friday, 11'th Dec 2020
MADISON, Wis., Dec. 11, 2020 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the presentation of new data at the virtual 2020 San Antonio Breast Cancer Symposium (SABCS) building o
Exact Sciences to participate in December investor conference
06:00am, Monday, 23'rd Nov 2020
MADISON, Wis., Nov. 23, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participa
Liquid Biopsy Cancer Testing Is The Next Big Investment Opportunity
09:25am, Tuesday, 17'th Nov 2020
Multiple companies are working on next-gen blood biopsies tech to detect cancer. The potential market size is big according to most estimates and analysts.
Forget Apple! Buy These 2 High-Growth Stocks Instead
08:08am, Saturday, 14'th Nov 2020
Instead of investing in the company that would have made you a millionaire years ago, seek out the ones that have the potential from here.
Stocks Rally To Cap Wild Week: Nio, Zoom Video Flash Sell Signals; Exact Sciences Trades Bullishly
04:18pm, Friday, 13'th Nov 2020
Stocks rally to cap wild week: Nio, Zoom Video flash sell signals; Exact Sciences trades bullishly. Investor's Business Daily has been helping people invest smarter results by providing exclusive stoc
Here's Why Exact Sciences Jumped 21.5% in October
09:06pm, Sunday, 08'th Nov 2020
A solid third quarter plus an acquisition to drive future growth has investors giddy.
Exact Sciences to participate in November investor conferences
06:00am, Monday, 02'nd Nov 2020
MADISON, Wis., Nov. 2, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participa
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q3 2020 Results - Earnings Call Transcript
12:13am, Friday, 30'th Oct 2020
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q3 2020 Results - Earnings Call Transcript
Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
04:35pm, Tuesday, 27'th Oct 2020
MADISON, Wis., Oct. 27, 2020 /PRNewswire/ -- The United States Preventive Services Task Force (USPSTF) today released draft updated colorectal cancer screening guidelines recommending that screening b
Exact Sciences soars 33% after agreeing to acquire early cancer detection firm for $2.15 billion (EXAS)
04:05pm, Tuesday, 27'th Oct 2020
Exact Sciences soared as much as 33% on Tuesday to record highs after the diagnostics company said it would acquire Thrive Earlier Detection for up to $2.15 billion in a stock and cash deal. Thrive Ea
Here's Why Exact Sciences Stock Rocketed Higher Today
02:09pm, Tuesday, 27'th Oct 2020
Solid earnings and a smart acquisition have investors hitting the buy button.
Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market
12:38pm, Tuesday, 27'th Oct 2020
Shares of cancer screening and diagnostics company EXACT Sciences Corporation (NASDAQ: EXAS) were rallying to a record high Tuesday after it announced two M&A transactions and third-quarter results.
Exact Sciences News: Why EXAS Stock Is Shooting 18% Higher Today
11:52am, Tuesday, 27'th Oct 2020
Exact Sciences (EXAS) stock was flying high on Tuesday following a flurry of news from the molecular diagnostics company. The post Exact Sciences News: Why EXAS Stock Is Shooting 18% Higher Today appe
Exact Sciences to acquire Thrive Earlier Detection Corp. in cash and stock deal worth up to $2.15 billion
07:15am, Tuesday, 27'th Oct 2020
Exact Sciences Corp. said Tuesday it has agreed to acquire Thrive Earlier Detection Corp. in a cash and stock deal worth up to $2.15 billion. Thrive Earlier is a health care company that aims to bring
Exact Sciences Announces Entry into Agreements to Sell $869 Million of Common Stock in Registered Direct Offering
07:10am, Tuesday, 27'th Oct 2020
MADISON, Wis., Oct. 27, 2020 /PRNewswire/ -- Exact Sciences Corporation (Nasdaq: EXAS) today announced the entry into agreements to sell an aggregate of 8,605,483 shares (the "Shares") of its common s
